Clinical Trials
10 trialsNCT05067842 2025-06-08
TRACT DNA
Medical College of Wisconsin
Withdrawn
NCT03778879 2019-07-19
Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B
University of Rochester
Phase 1/2 Withdrawn
NCT02943603 2018-07-13
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
University of Pittsburgh
Phase 2 Withdrawn
NCT01821196 2018-03-12
Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma
St. Olavs Hospital
Phase NA Withdrawn
NCT01045941 2016-10-06
Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Withdrawn
NCT00800969 2016-06-23
Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach
University of Zurich
Phase 2 Withdrawn
NCT02310971 2015-04-03
Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Prima BioMed Ltd
Phase 2 Withdrawn
NCT02205463 2014-08-01
KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer
NYU Langone Health
Phase 1 Withdrawn
NCT01600807 2013-06-26
OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas
Dana-Farber Cancer Institute
Phase 1/2 Withdrawn
NCT01175291 2011-12-05
FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn